All In Biotech

Free tool

FAERS Monitor: Phoxillum Bk 4/2.5 In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207026 or its brand name (Phoxillum Bk 4/2.5 In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride, Sodium Phosphate). Reports on generic versions are filed under their own applications.

Reports

12

Serious

6

50% of reports

Hospitalization

2

Death reported

4

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypotension3
  • blood phosphorus increased2
  • general physical health deterioration2
  • septic shock2
  • abdominal pain1
  • acute lymphocytic leukaemia recurrent1
  • blood glucose decreased1
  • blood potassium increased1
  • cardiogenic shock1
  • cardiopulmonary failure1
  • confusional state1
  • cytokine release syndrome1
  • cytopenia1
  • death1
  • end stage renal disease1

Reports by year received

View as table
YearReports
20173
20183
20192
20242
20251
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,147 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood phosphorus increased21284.9362.41,442
acute lymphocytic leukaemia recurrent1679.5104.0169
cardiopulmonary failure1449.668.8111
cytopenia1143.221.935
cardiogenic shock1122.118.730
blood potassium increased1108.016.526
end stage renal disease196.114.723
cytokine release syndrome187.413.421
septic shock280.622.788
blood glucose decreased136.55.68
general physical health deterioration230.38.531
hypotensionSignal326.29.850
confusional state110.81.72
abdominal pain17.51.21
death12.00.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.